Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Vernon

Showing results (1-10 of 52) with videos related to

Pageof 6
Sort By:
American Journal of Respiratory and Critical Care Medicine|March 26, 2010
A trial involving HIV-tuberculosis in India: the minute particularsAndrew Vernon
Seminars in Respiratory and Critical Care Medicine|March 6, 2013
Treatment of latent tuberculosis infectionAndrew Vernon
The Lancet. Infectious Diseases|April 13, 2015
Tuberculosis and vitamin D: what's the rest of the story?Peter Cegielski, Andrew Vernon
American Journal of Respiratory and Critical Care Medicine|November 26, 2019
Modeling Treatment of Latent Tuberculosis: Shortening the Leap of Faith?Andrew Vernon, William Bishai
American Journal of Respiratory and Critical Care Medicine|April 16, 2015
A reader's guide to the bactericidal activity of pyrazinamide and clofazimine alone and in combinations with pretomanid and bedaquilineJacques Grosset, Andrew Vernon
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|April 5, 2002
Another step on the path to better TB therapiesAndrew Vernon, William Burman, C Robert Horsburgh
Current Opinion in Pulmonary Medicine|March 11, 2010
New drugs and new regimens for the treatment of tuberculosis: review of the drug development pipeline and implications for national programmesChristian Lienhardt, Andrew Vernon, Mario C Raviglione
Plos Medicine|December 11, 2019
The importance of adherence in tuberculosis treatment clinical trials and its relevance in explanatory and pragmatic trialsAndrew Vernon, Katherine Fielding, Rada Savic, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|January 31, 2008
Advancing the science in clinical trials for new TB drugsWilliam Burman, David McNeeley, Lawrence H Moulton, et al.
Revista Panamericana De Salud Publica = Pan American Journal of Public Health|June 26, 2023
An initiative to improve mental health practice in primary care in Caribbean countriesBianca Lauria-Horner, Stephanie Knaak, Claudina Cayetano, et al.
Pageof 6

Showing results (1-10 of 52) with videos related to

Sort By:
Pageof 6
American Journal of Respiratory and Critical Care Medicine|March 26, 2010
A trial involving HIV-tuberculosis in India: the minute particularsAndrew Vernon
Seminars in Respiratory and Critical Care Medicine|March 6, 2013
Treatment of latent tuberculosis infectionAndrew Vernon
The Lancet. Infectious Diseases|April 13, 2015
Tuberculosis and vitamin D: what's the rest of the story?Peter Cegielski, Andrew Vernon
American Journal of Respiratory and Critical Care Medicine|November 26, 2019
Modeling Treatment of Latent Tuberculosis: Shortening the Leap of Faith?Andrew Vernon, William Bishai
American Journal of Respiratory and Critical Care Medicine|April 16, 2015
A reader's guide to the bactericidal activity of pyrazinamide and clofazimine alone and in combinations with pretomanid and bedaquilineJacques Grosset, Andrew Vernon
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|April 5, 2002
Another step on the path to better TB therapiesAndrew Vernon, William Burman, C Robert Horsburgh
Current Opinion in Pulmonary Medicine|March 11, 2010
New drugs and new regimens for the treatment of tuberculosis: review of the drug development pipeline and implications for national programmesChristian Lienhardt, Andrew Vernon, Mario C Raviglione
Plos Medicine|December 11, 2019
The importance of adherence in tuberculosis treatment clinical trials and its relevance in explanatory and pragmatic trialsAndrew Vernon, Katherine Fielding, Rada Savic, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|January 31, 2008
Advancing the science in clinical trials for new TB drugsWilliam Burman, David McNeeley, Lawrence H Moulton, et al.
Revista Panamericana De Salud Publica = Pan American Journal of Public Health|June 26, 2023
An initiative to improve mental health practice in primary care in Caribbean countriesBianca Lauria-Horner, Stephanie Knaak, Claudina Cayetano, et al.
Pageof 6